Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles

Viral Immunology

Volumn 24, Issue 3, 2011, Pages 189-198

  Peretz, Yoav ^a,b   Marra, Olivia ^b   Thomas, Réjean ^c   Legault, Danielle ^c   Côté, Pierre ^d   Boulassel, Mohamed Rachid ^e   Rouleau, Danielle ^f   Routy, Jean Pierre ^e   Sékaly, Rafick Pierre ^g   Tsoukas, Christos M ^b   Tremblay, Cécile ^f   Bernard, Nicole F ^b  

^a National Immune Monitoring Laboratory   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c Clinique Medicale l'Actuel   (Canada)

^d Clinique du Cartier Latin   (Canada)

^e ROYAL VICTORIA HOSPITAL   (Canada)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g Vaccine and Gene Therapy Institute of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA B27 ANTIGEN; HLA B57 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL;

ALLELES; ANTIGENS, VIRAL; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HIV; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HLA ANTIGENS; HUMANS; LYMPHOCYTE SUBSETS; MALE;

EID: 79959318055     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2010.0117     Document Type: Article

References (54)

1. Addo MM, Yu XG, Rathod A, Cohen D, et al.: Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003;77:2081-2092. (Pubitemid 36110021)
2. Almeida JR, Price DA, Papagno L, et al.: Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 2007;204:2473-2485. (Pubitemid 47529331)
3. Altfeld M, Kalife E, Qi Y, et al.: HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med 2006;3:e403.
4. Altfeld M, Kalife ET, Qi Y et al.: HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med 2006;3:e403.
5. Betts MR, Nason MC, West SM, et al.: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006;107:4781-4789. (Pubitemid 43882629)
6. Boulassel MR, Spurll G, Rouleau D, et al.: Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis. J Clin Apher 2003;18:55-60. (Pubitemid 36927375)
7. Boulet S, Ndongala ML, Peretz Y, et al.: A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J Immunol Methods 2007;320:18-29. (Pubitemid 46349097)
8. Brander C, Korber BT, Walker B, et al.: Recent advances in the optimization of HIV-specific CTL epitopes in the HIV Molecular Immunology Database. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, NM.
9. Brockman MA, Brumme ZL, Brumme CJ, et al.: Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol 2010;84:11937-11949. doi:JVI.01086-10 [pii];10.1128/JVI.01086-10 [doi].
10. Buchbinder S, and Vittinghoff E: HIV-infected long-term nonprogressors: epidemiology, mechanisms of delayed progression, and clinical and research implications. Microbes Infect 1999;1:1113-1120. (Pubitemid 29496094)
11. Carrington M, Nelson GW, Martin MP, et al.: HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
12. Carrington M, and O'Brien SJ: The influence of HLA genotype on AIDS. Annu Rev Med 2003;54:535-551. (Pubitemid 37386411)
13. Darrah PA, Patel DT, De Luca PM, et al.: Multifunctional Th1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007;13:843-850. (Pubitemid 47038186)
14. Draenert R, Verrill CL, Tang Y, et al.: Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol 2004;78:630-641. (Pubitemid 38067584)
15. Fellay J, Shianna KV, Ge D, et al.: A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317:944-947. (Pubitemid 47301321)
16. Frahm N, Korber BT, Adams CM, et al.: Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004;78:2187-2200. (Pubitemid 38228912)
17. Frater AJ, Brown H, Oxenius A, et al.: Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol 2007;81:6742-6751. (Pubitemid 46878078)
18. Geldmacher C, Currier JR, Herrmann E, et al.: CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol 2007;81:2440-2448.
19. Goulder PJ, Bunce M, Krausa P, et al.: Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses 1996;12:1691-1698. (Pubitemid 26424047)
20. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, and Pantaleo G: Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006;211:236-254. (Pubitemid 43882976)
21. Harari A, Petitpierre S, Vallelian F, and Pantaleo G: Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004;103:966-972. (Pubitemid 38129558)
22. Hendel H, Caillat-Zucman S, Lebuanec H, et al.: New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942-6946. (Pubitemid 29309424)
23. Hersperger AR, Pereyra F, Nason M, et al.: Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 2010;6:e1000917. doi:10.1371/journal.ppat.1000917 [doi].
24. Honeyborne I, Prendergast A, Pereyra F, et al.: Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ Tcell epitopes. J Virol 2007;81:3667-3672. (Pubitemid 46456679)
25. Hoover DR, Graham NM, Chen B, Taylor JM, Phair J, Zhou SY, and Munoz A: Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr 1992;5:794-802.
26. Horton H, Frank I, Baydo R et al.: Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol 2006;177:7406-7415. (Pubitemid 44715111)
27. Jansen CA, Kostense S, Vandenberghe K, et al.: High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection. Eur J Immunol 2005;35:150-158. (Pubitemid 40123861)
28. Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405-411. (Pubitemid 26193012)
29. Kaufmann DE, Bailey PM, Sidney J, et al.: Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol 2004;78:4463-4477. (Pubitemid 38501066)
30. Kiepiela P, Ngumbela K, Thobakgale C, et al.: CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2006;13:46-53. (Pubitemid 46067385)
31. Leslie A, Price DA, Mkhize P, et al.: Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J Immunol 2006;177:4699-4708. (Pubitemid 44469803)
32. Lichterfeld M, Yu XG, Waring MT, et al.: HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood 2004;104:487-494. (Pubitemid 38900032)
33. MacDonald KS, Fowke KR, Kimani J, et al.: Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000;181:1581-1589. (Pubitemid 30387748)
34. Masemola A, Mashishi T, Khoury G, et al.: Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol 2004;78:3233-3243. (Pubitemid 38568263)
35. McNeil AJ, Yap PL, Gore SM, et al.: Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM 1996;89:177-185. (Pubitemid 26086136)
36. Migueles SA, Laborico AC, Shupert WL, et al.: HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002;3:1061-1068. (Pubitemid 35363659)
37. Migueles SA, Osborne CM, Royce C, et al.: Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008;29:1009-1021. doi:S1074-7613(08)00501-3 [pii];10.1016/j.immuni.2008.10.010 [doi].
38. Migueles SA, Sabbaghian MS, Shupert WL, et al.: HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000;97:2709-2714. (Pubitemid 30159236)
39. Ndongala ML, Peretz Y, Boulet S, et al.: HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naive individuals in acute infection early disease (AIED) are associated with low viral load. Clin Immunol 2009;131:277-287. doi:S1521-6616(08)00912-1 [pii];10.1016/j.clim.2008.11.006 [doi].
40. O'Brien SJ, Gao X, and Carrington M: HLA and AIDS: a cautionary tale. Trends Mol Med 2001;7:379-381. (Pubitemid 32825514)
41. Palmer BE, Boritz E, and Wilson CC: Effects of sustained HIV-1 plasma viremia on HIV-1 gag-specific CD4+ T cell maturation and function. J Immunol 2004;172:3337-3347. (Pubitemid 38263726)
42. Pantaleo G, and Harari A: Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 2006;6:417-423.
43. Peretz Y, Alter G, Boisvert MP, Hatzakis G, Tsoukas CM, and Bernard NF: Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline. J Virol 2005;79:4908-4917. (Pubitemid 40464241)
44. Peretz Y, Ndongala ML, Boulet S, et al.: Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: Correlation of these functional T cell subsets with markers of disease progression. Clin Immunol 2007;124:57-68. (Pubitemid 46936252)
45. Sacha JB, Chung C, Rakasz EG, et al.: Gag-specific CD8+ T lymphocytes recognize infected cells Before AIDS-virus integration and viral protein expression. J Immunol 2007;178:2746-2754. (Pubitemid 46333151)
46. Scherer A, Frater J, Oxenius A, et al.: Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc Natl Acad Sci USA 2004;101:12266-12270. (Pubitemid 39145432)
47. Streeck H, Jolin JS, Qi Y, et al.: Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol 2009;83:7641-7648. doi:JVI.00182-09 [pii];10.1128/JVI.00182-09 [doi].
48. Streeck H, Lichterfeld M, Alter G, et al.: Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol 2007;81:7725-7731. (Pubitemid 47047858)
49. Tang J, Costello C, Keet IP, et al.: HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS ResHumRetroviruses 1999;15:317-324. (Pubitemid 29115924)
50. Turnbull EL, Lopes AR, Jones NA, et al.: HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol 2006;176:6130-6146.
51. Ueno T, Idegami Y, Motozono C, Oka S, and Takiguchi M: Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs. J Immunol 2007;178:5513-5523. (Pubitemid 46674346)
52. Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP, and Sekaly RP: HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003;198:1909-1922. (Pubitemid 38032123)
53. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, and Pantaleo G: HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA 2005;102:7239-7244. (Pubitemid 40696363)
54. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, and Pantaleo G: HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA 2005;102:7239-7244. (Pubitemid 40696363)